Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CymaBay Therapeutics Inc.

    NASDAQ: CBAY · Real-Time Price · USD
    32.48
    0.01 (0.03%)
    At close: Mar 21, 2024, 9:00 PM

    CymaBay Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 31.07M n/a n/a
    Cost of Revenue
    		 681K 710K 688K
    Gross Profit
    		 30.39M -710K -688K
    Operating Income
    		 -101.68M -93.11M -87.58M
    Interest Income
    		 13.49M 2.02M 167K
    Pretax Income
    		 -105.37M -106M -90M
    Net Income
    		 -105.37M -118.89M -92.58M
    Selling & General & Admin
    		 51.95M 25.12M 23.04M
    Research & Development
    		 80.12M 68M 64.54M
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 132.07M 93.11M 87.58M
    Interest Expense
    		 18.95M 14.91M 2.58M
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 132.75M 93.11M 87.58M
    Income Tax Expense
    		 n/a 12.89M 2.58M
    Shares Outstanding (Basic)
    		 106.2M 87.8M 71.06M
    Shares Outstanding (Diluted)
    		 106.2M 87.8M 71.06M
    EPS (Basic)
    		 -0.99 -1.35 -1.3
    EPS (Diluted)
    		 -0.99 -1.35 -1.3
    EBITDA
    		 -85.74M -92.4M -86.73M
    EBIT
    		 -86.42M -91.09M -87.42M
    Depreciation & Amortization
    		 681K 2.02M 855K

    Add to Watchlist